Nectar Lifesciences

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue464.86451.48460.25514.01514.68
Expenses403.55391.53406.93450.19431.72
EBITDA37.7036.0137.4742.6749.98
EBIT22.8520.6822.1627.3035.28
Profit Before Tax3.193.061.652.4611.12
Net Profit5.361.821.021.570.60
Financial Ratios
Operating Profit Margin8.45%7.98%8.33%8.31%9.77%
Net Profit Margin1.20%0.40%0.23%0.31%0.12%
Earning Per Share (Diluted)0.240.080.050.070.03
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ